The Intermediate-Activity L597VBRAF Mutant Acts as an Epistatic Modifier of Oncogenic RAS by Enhancing Signaling Through the RAF/MEK/ERK Pathway

Genes and Development - United States
doi 10.1101/gad.193458.112